0001567892 false 0001567892 2023-03-07 2023-03-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 7, 2023

 

Mallinckrodt plc

(Exact name of registrant as specified in its charter)

 

Ireland 001-35803 98-1088325
(State or other jurisdiction
of incorporation)		 (Commission
File Number)		 (IRS Employer
Identification No.)

 

College Business & Technology Park, Cruiserath,
Blanchardstown, Dublin 15, Ireland

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code:  +353 1 696 0000

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

(Title of each class) (Trading Symbol(s)) (Name of each exchange on which registered)
Ordinary shares, par value $0.01 per share MNK NYSE American LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ¨

 

 

 

   

 

 

Item 7.01 Regulation FD Disclosure.

 

On March 7, 2023, Mallinckrodt plc will make a presentation at Cowen’s 43rd Annual Health Care Conference in Boston, Massachusetts. A copy of the presentation is furnished with this report as Exhibit 99.1. Individuals who cannot attend the meeting in person can find webcast information on the Company’s investor relations page at ir.mallinckrodt.com.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No.   Exhibit
99.1   Presentation Provided By Mallinckrodt plc on March 7, 2023
104   Cover Page Interactive Data File (embedded within the inline XBRL document).

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    MALLINCKRODT PLC
     
    (registrant)
     
Date: March 7, 2023 By: /s/ Mark Tyndall
    Mark Tyndall 
     
    Executive Vice President, Chief Legal Officer & Corporate Secretary 

 

 

 

 

 

Mallinckrodt () (USOTC:MNKKQ)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Mallinckrodt () Charts.
Mallinckrodt () (USOTC:MNKKQ)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Mallinckrodt () Charts.